ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2184

CaMK4 Controls the Humoral Response via the T Follicular Helper Compartment and Regulates Autoimmunity

Marc Scherlinger1, Hao Li2, Wenliang Pan2, Maria Tsokos1 and George Tsokos2, 1BIDMC Harvard University, Boston, MA, 2Division of Rheumatology and Clinical Immunology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA

Meeting: ACR Convergence 2022

Keywords: autoimmune diseases, immunology, signal transduction, Systemic lupus erythematosus (SLE), T Cell

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: T Cell Biology and Targets in Autoimmune and Inflammatory Disease

Session Type: Abstract Session

Session Time: 3:00PM-4:00PM

Background/Purpose: Systemic lupus erythematosus (SLE) is characterized by a dysregulated T cell compartment and production of autoantibodies leading to organ damage. We previously identified that activity of Calcium/Calmodulin-dependent protein kinase (CaMK4) is increased in SLE T cell and that a Camk4 global knockdown leads to decreased autoantibody levels and improved lupus-like disease in the MRL/lpr lupus-prone mouse (1). Since CaMK4 is not expressed in the B cell compartment, we hypothesized that CaMK4 was important for the T-dependent B cell response.

Methods: Gene expression was evaluated using quantitative-reverse transcriptase PCR. We used two T cell-dependent antigens, sheep red blood cells (SRBC) and NP-Chicken gamma globulin (NP-CGG), to immunize C57BL/6 mice with a T-cell specific Camk4 knockdown (B6.Camk4fl/fl.dlckCre) or not (B6.Camk4fl/fl) by intraperitoneal injection. Following immunization, we studied the T follicular helper (Tfh; CD4+CD44+CXCR5+PD1+) T cells and germinal center (GL7+CD95+) B cells populations in the spleen and cervical lymph nodes (cLN) using flow cytometry. Luciferase assay using the Bcl6 promoter cloned on the pGL3 vector was used to investigate the control of Bcl6 transcription .Serum IgM and IgG responses to NP-CGG were evaluated using ELISA. To translate our findings to autoimmunity, we used the lupus-like B6.lpr murine model crossed with the Camk4fl/fl.dlckCre mouse and studied the Tfh compartment, autoantibody levels and the severity of the disease.

Results: We identified that primary murine Tfh express high level of Camk4, similar to Tconv and T regulatory cell, and unlike B cells which do not express any. Compared to CaMK4-sufficient littermates, B6.Camk4fl/fl.dlckCre mice were characterized by a dampened expansion of the Tfh compartment 7 days post-SRBC immunization, in the spleen and cLN (p < 0.001 for both comparisons; Fig. 1A-B). Conversely, immunized B6.Camk4fl/fl.dlckCre had decreased germinal center B cells compared to Cre-negative littermates. In terms of humoral response, B6.Camk4fl/fl.dlckCre had decreased IgG1 and IgG2b response to NP-CGG immunization. Mechanistically, preliminary data suggest that the Bcl6 gene expression is controlled by CaMK4 through the transcriptional repressor CREMa, as determined by a luciferase reporter assay. In lupus B6.lpr mice, T-cell specific knockdown of Camk4 led to decreased circulating, splenic and cLN Tfh and germinal center cells without any change in the FoxP3+ regulatory Tfh cells. Additionally, splenic plasma cells and age-related B cells were decreased in B6.lpr.Camk4fl/fl.dlckCre mice compared to CaMK4-sufficient littermates. This translated into decreased anti-dsDNA IgG1 and IgG2b levels, decreased IgG/C3 staining in kidney immunofluorescence and improved kidney pathology.

Conclusion: We identified that CaMK4 expression is instrumental for the expansion of the Tfh compartment, and for the promotion in T-dependent B cell response in the mouse models of immunization and autoimmunity. The characterization of molecular mechanisms underlying systemic autoimmunity may lead the identification of new therapeutic opportunities in SLE.

Reference:

1. Koga T, et al. J Immunol. 2012 Oct 1;189(7):3490–6.

Supporting image 1

Figure 1: B6.Camk4fl/fl and B6.Camk4fl/fl.dlckCre mice were immunized with 100µL of 10% sheep red blood cells by intraperitoneal injection. One week after, the mice were sacrificed and the spleen and cervical lymph nodes (cLN) were studied using cytometry.
(A) Gating strategy for the T follicular helper cell analysis. (B) Cumulative results of splenic and cLN activated Tfh 7 days after immunization. Each point represents one mice and bars indicate s.e.m. ***, p < 0.001 using one-way ANOVA with Sidak's correction.


Disclosures: M. Scherlinger, Sandoz, Amgen, Nordic Pharma; H. Li, None; W. Pan, None; M. Tsokos, None; G. Tsokos, None.

To cite this abstract in AMA style:

Scherlinger M, Li H, Pan W, Tsokos M, Tsokos G. CaMK4 Controls the Humoral Response via the T Follicular Helper Compartment and Regulates Autoimmunity [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/camk4-controls-the-humoral-response-via-the-t-follicular-helper-compartment-and-regulates-autoimmunity/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/camk4-controls-the-humoral-response-via-the-t-follicular-helper-compartment-and-regulates-autoimmunity/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology